"RESEARCH & DEVELOPMENT CHIEF, CARB-X (REMOTE)"

RESEARCH & DEVELOPMENT CHIEF, CARB-X (REMOTE)

Job Location

Remote (Worldwide)

Salary Grade

Competitive

Expected Hiring Range Minimum: $290,000.00

Expected Hiring Range Maximum: $330,000.00

The salary of the finalist selected for this role will be set based on a variety of factors, including but not limited to departmental budgets, qualifications, experience, education, licenses, specialty, training and internal pay comparison. The above hiring range represents the University's good faith and reasonable estimate of the range of possible compensation at the time of posting.

Position Type

Full-Time/Regular

Company background

CARB-X is the world's leading public-private partnership accelerating the early-stage development of innovative products to treat, prevent, and diagnose life-threatening bacterial infections. CARB-X is generously supported by multiple governments and private foundations, which entrusts the initiative with an annual budget of more than USD 100 million. The CARB-X team is virtual, based in multiple countries across different time zones. The four values that CARB-X prioritizes across the organization are collaboration, humility, integrity and excellence. The work environment is creative, dynamic and energetic.

CARB-X advances early-stage product development, funding R&D projects from lead discovery to the completion of first-in-human trials (and occasionally beyond). It provides non-dilutive funding, scientific expertise, regulatory support, and business acceleration tools to product developers worldwide, especially small- and medium-sized companies and university product development teams.

Since 2017, the year of the first investment, CARB-X has supported the development of more than 100 products, 22 of which entered or completed first-in-human clinical trials. Among these, 3 are on the market and 10+ have advanced development partnerships. As the portfolio has matured, CARB-X is increasingly involved in human clinical trials.

The role

CARB-X seeks a Chief of R&D to provide scientific leadership, lead the execution of its product development strategy, and manage a high-performing virtual R&D team. This can be a fully virtual position, based in any location that will support very active collaboration with colleagues in Europe and the United States. In the coming years, CARB-X expects to make new investments of more than USD 100 million on an annual basis, making the role of the Chief of R&D globally prominent and strategic for antibacterial R&D. The recommendation to support an R&D project is made by the R&D team after advice from external Advisory Boards. The final decision is made by the CARB-X Investment Committee. The Chief of R&D leads the team that identifies and translates strategic priorities into publicly announced funding calls, after approval from our board, contributing robust pre-award processes and investment recommendations, while also overseeing post-award support and portfolio transitions.

Reporting directly to the Executive Director and working in close partnership with the other members of the Executive Team, the role is expected to foster collaboration throughout the organization and across the AMR ecosystem, strengthening CARB-X's scientific influence, and ensuring product developers are positioned for successful progression into clinical and regulatory pathways and market entry. CARB-X will ultimately be judged by its ability to collaborate with upstream and downstream partners, and by the impact of the products it helped deliver to patients in need globally.

Required Skills

Relevant experience
The ideal candidate should bring strong, science-driven leadership credentials, specifically:

• Senior leadership in R&D, within a fast-paced biotech and/or pharma environment (ideally both) and focused on strategic approaches to addressing infectious diseases.
• Management of high-performing R&D teams, including performance management, and organizational development, ideally in a virtual or matrixed structure, leading through delegation.
• Exposure across many phases of R&D, from discovery through development and ideally commercialization, including experience with milestone-based portfolios.
• Demonstrated success progressing multiple assets - therapeutics, preventatives, and/or diagnostics - ideally in infectious diseases/AMR.
• Ability to communicate scientific strategy to a wide stakeholder audience: funders, regulators, advisors, investors, and ecosystem partners.
• Strong global scientific network (academic KOLs, biopharma leaders, investigators), ideally with influence across the infectious disease ecosystem, including historically under-represented settings.
• A demonstrated commitment to understanding the complexities of global supply chains and access barriers, given that the burden on AMR is significant across all income levels but disproportionally affects individuals in low-resource settings.
• Significant budget authority and investment decision experience, ideally in either grant funded or portfolio investment environments.
• Track record of leading external scientific and clinical collaborations across academia, advisors, and industry.

CARB-X has appointed global search firm Egon Zehnder to support this search. Applications received by CARB-X may be forwarded to Egon Zehnder. Due to the anticipated volume of applications for this position, only those who have been selected for further consideration will be contacted. Details of Egon Zehnder's privacy policy can be found at https://www.egonzehnder.com/privacy-policy.

We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, natural or protective hairstyle, religion, sex, age, national origin, physical or mental disability, sexual orientation, gender identity, genetic information, military service, pregnancy or pregnancy-related condition, or because of marital, parental, or veteran status. We are a VEVRAA Federal Contractor.